Induced sputum is a particularly useful procedure since it provides information on the cellular and molecular constituents in inflammation. Extensive work has demonstrated the application of induced sputum in the management of asthma, chronic obstructive pulmonary disease and chronic bronchitis, but less attention has been paid to its efficacy in diagnosing interstitial lung diseases. This review analyzes the applications of induced sputum in the assessment of sarcoidosis, nongranulomatous interstitial lung diseases, occupational lung diseases and other systemic diseases with or without lung involvement. Recent findings T cell subsets in induced sputum in combination with pulmonary function testing can serve as predictors with high specificity and sensitivity in diagnosing sarcoidosis, using multivariate logistic regression models which can be easily implemented in clinical practice. Differential cell counts in induced sputum are as useful as bronchoalveolar lavage for identifying neutrophilic inflammation in patients with nongranulomatous interstitial lung diseases (e.g. idiopathic pulmonary fibrosis) and detecting chronic rejection in bronchiolitis obliterans syndrome. Sputum analysis has also been shown to be a useful tool for diagnosing, assessing and monitoring occupational lung disorders. Summary We suggest integrating induced sputum technology to the well-established criteria for the diagnosis of interstitial lung diseases, especially when there are clinical contraindications for performing bronchoscopy or when tissue confirmation is absent for any reason. More than 800 papers have been published between 1992 and 2006 on the application of induced sputum in the management of obstructive lung diseases, but much less attention has been paid to the application of this technique in diagnosing interstitial lung diseases (ILDs). Our group was the first to investigate the use of induced sputum in this group of pathologies. We compared induced sputum to bronchoalveolar lavage (BAL) in the assessment of exposure to hazardous dust and in the evaluation of pneumoconiotic patients (silica and hard metal workers) [6] , and also demonstrated the ability of induced sputum to study acute and chronic occupational exposures [7] [8] [9] .
Introduction
There is an ongoing search for noninvasive procedures that can either act as substitutes for bronchoscopy when there are clinical contraindications for performing it or provide complementary information to that acquired by bronchoscopy. One technique -induced sputum -is now in widespread use [1] . Another involves testing the nitric oxide that arises from the airway and alveolar compartments in the assessment of lung inflammation [2] . Inflammatory mediators have been identified in the exhaled breath condensate that is formed by breathing through a cooling system [3] , but the only current noninvasive method which allows direct study of soluble mediators [4] with cellular components [5] in the lung is induced sputum.
More than 800 papers have been published between 1992 and 2006 on the application of induced sputum in the management of obstructive lung diseases, but much less attention has been paid to the application of this technique in diagnosing interstitial lung diseases (ILDs). Our group was the first to investigate the use of induced sputum in this group of pathologies. We compared induced sputum to bronchoalveolar lavage (BAL) in the assessment of exposure to hazardous dust and in the evaluation of pneumoconiotic patients (silica and hard metal workers) [6] , and also demonstrated the ability of induced sputum to study acute and chronic occupational exposures [7] [8] [9] .
We [10] and others [11] [12] [13] [14] showed that induced sputum can potentially identify other ILDs of unknown etiology, such as sarcoidosis and idiopathic pulmonary fibrosis (IPF). In cases of sarcoidosis, induced sputum can fulfill the same criteria as BAL by virtue of its ability to detect a high percentage of lymphocytes with CD4 predominance [11] [12] [13] [14] . This is especially true in patients with uveitis [15] or Crohn's disease [16] with no apparent pulmonary involvement, where there are ethical problems associated with performing bronchoscopy.
The scope of the present review is to describe the everexpanding role of induced sputum in clinical practice, and show how this noninvasive assessment of airway inflammation can add significant and relevant information to that already provided by history, physical examination, lung function and imaging data.
Induce sputum in interstitial lung diseases
ILD is a group of diseases of unknown etiology which produce diffuse pathologic changes, primarily in interalveolar interstitial tissue. BAL is a standard tool for the assessment of pulmonary diseases in general [17] and the differential cell count step is part of the routine work-up in evaluating ILD [18] . BAL, however, is a relatively invasive procedure that bears the drawbacks of patient discomfort in addition to the inherent possible risks associated with invasive techniques. Several studies [19, 20] have favorably compared induced sputum to BAL findings. We and others [10] [11] [12] [13] [14] demonstrated that the results of induced sputum and BAL are comparable with regard to the high percentage of lymphocytes and the predominance of CD4 in sarcoidosis. In a recent study [21] , BAL evaluation of the CD4/CD8 ratio was found to be superior (by a factor of 2) to differential counts of lymphocytes and neutrophils. Comparisons between both techniques were performed in hypersensitivity pneumonitis [22] and in IPF [23] as well. Those studies demonstrated that both BAL and induced sputum contained significantly more total cells and lymphocytes in patients with hypersensitivity pneumonitis compared with healthy subjects, and that there was a significant correlation between BAL fluid and induced sputum eosinophil counts and the CD4 þ /CD8 þ ratio in patients with IPF.
The findings of these comparative studies on techniques for retrieving lung material raise the question of whether induced sputum can surrogate BAL in the management of ILD. This has been shown to be the case for sarcoidosisinduced sputum fulfill the same criteria as BAL as a diagnostic tool by virtue of its ability to identify a high percentage of lymphocytes with CD4 predominance. According to the definition of the American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders [24] , there is a consensus that sarcoidosis is characterized by the T helper 1 response with accumulation of CD4 þ T lymphocytes and activated macrophages in the lung, resulting in the typical alveolitis response [10] [11] [12] [13] . In a recent retrospective study [25] , we investigated the potential application of the CD4/CD8 ratio of T lymphocytes in sputum in combination with functional parameters to differentiate sarcoidosis from nonsarcoid ILD. We included 120 patients (67 sarcoidosis and 53 nonsarcoid ILD) who underwent both BAL with transbronchial biopsy, induced sputum testing and high-resolution computerized tomography. We applied two multivariate logistic regression models to the data in order to predict the probability of having the sarcoidosis as a function of the explanatory variables: Model I contained demographic and induced sputum data, and Model II included demographic data and combined sputum and pulmonary function test (PFT) results. The area under the curve was 0.899 for induced sputum parameters alone, and 0.914 for induced sputum and PFT parameters, thus demonstrating that the results of this noninvasive approach can be used as predictors with high specificity and sensitivity in the differential diagnosis of sarcoidosis. Patients with ocular sarcoidosis and elevated angiotensin-converting enzyme in serum also had high CD4/CD8 ratios in induced sputum [15] . The accumulation of CD4 T lymphocytes in sputum is supported by the data showing traffic between the bronchoalveolar space to the bronchial lamina propria. In cases of sarcoidosis, these lymphocytes showed an increased motility which might conceivably facilitate their accumulation in the epithelium [26] , producing epithelioid granulomatosis [27] . All these findings supported the use of induced sputum secretions, retrieved mainly from mucus clearance of central airways, in diagnosing diseases of peripheral airways and alveolar spaces.
We were also able to show [16] that pulmonary involvement can be demonstrated in patients with Crohn's disease by the accumulation of CD4 þ T cells in induced sputum, thus lending credence to the concept of an uninterrupted recirculation and dynamic balance of CD4 þ lymphocytes from mucosa-associated lymphoid tissue to effector sites in the integrated human mucosal immune system [28, 29] .
In the evaluation of IPF, induced sputum is as useful as BAL for showing the presence of an accumulation of inflammatory cells, particularly neutrophils, in the alveolar space. Moreover, levels of sputum interleukin-8 were correlated with the percentage of neutrophils and vital capacity in all IPF patients [30] . Finally, the induced sputum differential eosinophil cell count and the median eosinophilic cationic protein count, which are significantly higher in patients with IPF, can be used to identify increased cough reflex sensitivity in those patients [31] .
Induced sputum in occupational lung diseases
By virtue of it being a safe and simple procedure, induced sputum was investigated for its ability to assess occupational exposures [32 ] . Several investigators showed the relevance of asbestos bodies present in spontaneous sputum compared with BAL. In this setting, induced sputum was much less sensitive than BAL fluid analysis and useful only in workers with high levels of exposure [33] . Although another group of investigators [34] found agreement of asbestos body detection in only 56.8% of their cases, they concluded that the two methods (BAL and induced sputum) were complementary since both are useful in increasing the probability of detection.
Our evaluation [6] of silica-and hard metal-exposed workers revealed that BAL and induced sputum yielded similar quantitative and qualitative results in terms of the number of particles present in the samples and the chemical analysis of the particles. The qualitative analysis of chemical particles was performed by scanning electron microscopy, while the quantitative analysis was done by the Cis-100 analyzer (Ankersmid, Yokneam, Israel), which allows a rapid analysis using minute quantities of biological material. The results showed that around 70% of particles internalized by macrophages or epithelial cells which are present in induced sputum as well as in BAL samples were smaller than 2.5 mm. These particles represent the largest fraction of the weight of the dust that can enter the lower lung fields. We hypothesized that the quantitative and qualitative analysis of particles recovered by induced sputum, as shown in that study, can serve as a biological monitoring method as part of the periodic health examinations of healthy workers exposed to hazardous dusts, supplementing traditional occupational parameters of past history and environmental measurements. This screening would be very much like the current biological monitoring of workers exposed to toxic agents, such as metals (e.g. lead, cadmium) and solvents (e.g. toluene, trichloroethane), that is carried out by measuring them or their metabolite in blood, urine or exhaled air [35] .
We also described [36] a fatal case of accelerated silicosis with a component of mixed pneumoconiosis in a patient who had been a hard metal grinder. We were able to demonstrate a good agreement between the BAL and induced sputum findings, with the polarizing light microscopic studies of both BAL and induced sputum having shown polarizing particles typical for silica.
We note that these procedures were performed under optimal clinical laboratory conditions. The use of induced sputum for large-scale screening of workers would necessitate the performance of induction at the workplace, since transporting the examinees can cause unacceptable inconvenience in the work schedule. In this context, we attempted to conduct sputum induction of foundry workers at the workplace itself, during routine periodic health examinations. Our objectives were to assess whether the distribution of particles size in induced sputum specimens was different between exposed and nonexposed workers, whether smoking was a confounder of the association, and whether there was a correlation between the distribution of particles size and the results of these workers' PFTs. Our results showed that there were significant differences in the proportion of particles with diameters above 2 and above 5 mm between the exposed and nonexposed groups. There also was a positive correlation between the proportion of particles above 5 mm and the forced expiratory volume at 1 s/forced vial capacity ratio for all 54 workers, as well as a significant correlation for nonsmokers [6] .
We then described [7] how induced sputum can assist in the evaluation and diagnosis of suspected occupational lung diseases. The three patients we evaluated included a miner with silicosis, a dental technician with chronic beryllium disease and a teacher who suffered from undefined interstitial fibrosis. Chemical analysis was done by scanning electron microscopy/energy dispersive spectroscopy and petrographic microscopy. The miner had worked under Nazi captivity in Silesia (central Europe) and was referred for induced sputum analysis due to progressive shortness of breath. The patient's chest computerized tomography showed diffuse interstitial fibrosis. PFT revealed a restrictive pattern with decrease in diffusion capacity. Analysis of induced sputum demonstrated clay minerals, quartz, aluminum and asbestos fibers. The dental technician with sarcoidosis was referred for induced sputum and the beryllium lymphocyte proliferation test to rule out a possible misdiagnosis of silicosis/chronic beryllium disease. Induced sputum analysis showed abundant particles of AlSiFe, AlSiCa, Al2Si 4 (OH) 2 , SiO 2 and BaSO 4 . The beryllium lymphocyte proliferation test showed positive results. The third case was a nonsmoker teacher who had used blackboard chalks as part of her daily work for 24 years. Due to worsening of her functional parameters, she underwent lung transplantation. Induced sputum and tissue biopsy analysis revealed that the most abundant particles were those of calcium sulfate (CaSO 4 ), silica (SiO 2 ), and silicates (SiCaFe and AlSi).
We had the opportunity to diagnose a sarcoid-like lung granulomatous disease that was aluminum induced [37] . Mineralogical analysis of induced sputum was key to the identification of the metal whose antigenic properties caused the granulomatous response. Recovered T cell subsets disclosed a CD4 alveolitis and the transbronchial biopsy showed sarcoid-like epithelioid granulomata. Peripheral blood lymphocytes exhibited blastic transformation in the presence of soluble aluminum compounds.
After the disaster at the World Trade Center in New York, we conducted a study [38] to determine whether induced sputum samples from highly exposed firefighters who had been caught in the dust cloud demonstrated a unique pattern of inflammation and particulate matter deposition compatible with World Trade Center dust 10 months postcollapse. Their induced sputum differential cell counts differed from healthcare worker controls, but not from firefighters in Tel Aviv. The neutrophil and eosinophil counts increased with greater intensity of World Trade Center exposure and their metalloproteinase-9 levels positively correlated percentage neutrophil counts. The particles were larger and more irregularly shaped in the exposed New York group (1-50 mm: zinc, mercury, gold, tin, silver) than in the Tel Aviv group (1-10 mm: silica, clays).
Induced sputum in other interstitial lung diseases
Lung transplantation has become a therapeutic option for a growing number of patients with end-stage lung disease [39] . Chronic rejection is often referred to as bronchiolitis obliterans syndrome. Transbronchial biopsy, which carries some potential risks (e.g. alveolar bleeding or pneumothorax), is the gold standard for detecting histological changes in bronchiolitis obliterans syndrome allografts [40] . The emerging need for noninvasive procedures to evaluate lower respiratory tract inflammation in lung transplant patients motivated a study [41] on 25 singleand 16 double-transplant patients and 15 healthy volunteers with the aim of establishing sputum cell counts related to chronic transplant rejection. Patients from both transplant groups who suffered chronic rejection had increased sputum neutrophils inversely correlated with forced expiratory volume at 1 s, compared with normal transplant function. These data were supported by other recent research [42] that proposed a possible role for neutrophils in the pathogenesis of chronic transplant rejection.
In a study [43] to differentiate pulmonary involvement in systemic lupus erythematosus with and without antiphospholipid antibodies or antiphospholipid syndrome, we found lower CD4 counts in the studied systemic lupus erythematosus groups compared with patients with primary antiphospholipid syndrome, suggesting the presence of subclinical ILD in these patients who were asymptomatic for respiratory symptoms.
Induced sputum in interstitial lung disease research
BAL is useful for sampling the epithelial lining fluid of the respiratory tract for research purposes; however, because of the relatively invasive nature of the procedure, there are few conditions for which repeat sampling can be justified. In this context, monitoring of treatment is optimally performed by induced sputum.
For instance, response to treatment was investigated [12] in induced sputum showing a fall in tumor necrosis factor-a levels following 6 months of steroids treatment which was parallel to the fall in BAL fluid levels in sarcoidosis patients. The role of interleukin-18 as an inflammatory molecule in the pathogenesis of IPF was recently studied [44 ] in correlation with its significant decrease after 12 months of therapy with interferon-g1b. In other research works, metalloproteinase-9 was demonstrated to be an indicative molecule involved in the remodeling processes in sarcoidosis [45] 
Conclusions
During its first stages of development, induced sputum methodology had generally been considered limited to serving as a research tool, similar to the reception of flexible bronchoscopy and BAL when they were first introduced in the 1970s. Induced sputum is now finding its way into clinical practice for the management of ILD. We believe that this procedure can be an integrative noninvasive tool in the diagnostic flow chart of ILD.
